Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma
Clinical trial NCT03682796 · COMPLETED
Trial details
- NCT number
- NCT03682796
- Sponsor
- Triphase Research and Development III Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2021-11-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.